May 6th 2025
Primaquine safely and effectively blocks malaria transmission across age-groups and different rates of regional transmission, leading to call for lower, pediatric-appropriate dose formulation.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
View More
Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice
View More
Study Uncovers Genetic Factors Behind Leishmaniasis Outcomes
November 25th 2019A new study published in Science Translational Medicine reveals that genetic testing can identify patients with leishmaniasis unlikely to respond to conventional treatments, allowing clinicians to find candidates for alternative therapies ahead of time.
Read More
EEE Threat Level Raised in Massachusetts Following First Fatality
September 2nd 2019The total number of communities at critical risk of the mosquito-borne Eastern equine encephalitis stands at 28 statewide. Thirty-seven other towns are considered at high risk for EEE, while 126 are at moderate risk.
Read More